{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:40:10Z","timestamp":1762674010157,"version":"3.40.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pbb.2014.12.006","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T05:08:13Z","timestamp":1419397693000},"page":"65-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model"],"prefix":"10.1016","volume":"129","author":[{"given":"Rita","family":"Citraro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0061-1608","authenticated-orcid":false,"given":"Antonio","family":"Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"De Fazio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Gallelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-8123","authenticated-orcid":false,"given":"Emilio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2014.12.006_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1472-8206.2010.00923.x","article-title":"Increased blood oxidative stress in experimental menopause rat model: the effects of vitamin A low-dose supplementation upon antioxidant status in bilateral ovariectomized rats","volume":"26","author":"Behr","year":"2012","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0010","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/0976-7800.118991","article-title":"Emerging therapies for the treatment of osteoporosis","volume":"4","author":"Bhutani","year":"2013","journal-title":"J Mid-Life Health"},{"key":"10.1016\/j.pbb.2014.12.006_bb0015","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pbb.2014.12.006_bb0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00104-X","article-title":"The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain","volume":"676","author":"Burnet","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0025","doi-asserted-by":"crossref","first-page":"E97","DOI":"10.9778\/cmajo.20130036","article-title":"Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study","volume":"1","author":"Cadarette","year":"2013","journal-title":"CMAJ Open"},{"key":"10.1016\/j.pbb.2014.12.006_bb0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0028-3908(02)00340-4","article-title":"Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain","volume":"44","author":"Castro","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.12.006_bb0035","doi-asserted-by":"crossref","first-page":"455","DOI":"10.33549\/physiolres.931382","article-title":"Alendronate lowers cholesterol synthesis in the central nervous system of rats\u2014a preliminary study","volume":"58","author":"Cibickova","year":"2009","journal-title":"Physiol Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0040","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2014.12.006_bb0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00236804","article-title":"Effect of acute and chronic 17 beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat","volume":"51","author":"Di Paolo","year":"1983","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0050","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.euroneuro.2007.07.007","article-title":"5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus","volume":"18","author":"Dos Santos","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0055","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1177\/0269881111408456","article-title":"Long-term ovariectomy modulates the antidepressant-like action of estrogens, but not of antidepressants","volume":"25","author":"Estrada-Camarena","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0060","first-page":"1869","article-title":"Effects of estrogen, estrogen\/progesteron combination and genistein treatments on oxidant\/antioxidant status in the brain of ovariectomized rats","volume":"17","author":"Evsen","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.pbb.2014.12.006_bb0065","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/eurpub\/ckt199","article-title":"Association of physical activity with future mental health in older, mid-life and younger women","volume":"24","author":"Griffiths","year":"2014","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.pbb.2014.12.006_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0169-328X(01)00108-5","article-title":"Estrogen receptor beta (ERbeta) mRNA and protein in serotonin neurons of macaques","volume":"91","author":"Gundlah","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0075","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2165\/00023210-200115100-00005","article-title":"Role of estrogen in the aetiology and treatment of mood disorders","volume":"15","author":"Halbreich","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pbb.2014.12.006_bb0080","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12020-008-9087-5","article-title":"Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques","volume":"33","author":"Henderson","year":"2008","journal-title":"Endocrine"},{"key":"10.1016\/j.pbb.2014.12.006_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jchemneu.2003.10.002","article-title":"The human raphe nuclei and the serotonergic system","volume":"26","author":"Hornung","year":"2003","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pbb.2014.12.006_bb0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2147\/CIA.S37199","article-title":"Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation","volume":"8","author":"Imai","year":"2013","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.pbb.2014.12.006_bb0095","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0169-6009(91)90124-I","article-title":"The ovariectomized rat model of postmenopausal bone loss","volume":"15","author":"Kalu","year":"1991","journal-title":"Bone Miner"},{"key":"10.1016\/j.pbb.2014.12.006_bb0100","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kwt188","article-title":"Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States","volume":"178","author":"Keyes","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S1701-2163(15)30489-8","article-title":"Osteoporosis in menopause. Journal of obstetrics and gynaecology Canada : JOGC =","volume":"36","author":"Khan","year":"2014","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.pbb.2014.12.006_bb0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.bbr.2011.10.047","article-title":"17beta-estradiol replacement in young, adult and middle-aged female ovariectomized rats promotes improvement of spatial reference memory and an antidepressant effect and alters monoamines and BDNF levels in memory- and depression-related brain areas","volume":"227","author":"Kiss","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0115","first-page":"110","article-title":"Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene","volume":"30","author":"Le Saux","year":"2005","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pbb.2014.12.006_bb0120","first-page":"424","article-title":"The laboratory rat as an animal model for osteoporosis research","volume":"58","author":"Lelovas","year":"2008","journal-title":"Comp Med"},{"key":"10.1016\/j.pbb.2014.12.006_bb0125","first-page":"188","article-title":"Established and forthcoming drugs for the treatment of osteoporosis","volume":"71","author":"Lems","year":"2013","journal-title":"Neth J Med"},{"key":"10.1016\/j.pbb.2014.12.006_bb0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1177\/154405910608500703","article-title":"Bone remodeling in post-menopausal osteoporosis","volume":"85","author":"Lerner","year":"2006","journal-title":"J Dent Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0135","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pbb.2014.12.006_bb0140","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1073\/pnas.1007640108","article-title":"Reversible modulations of neuronal plasticity by VEGF","volume":"108","author":"Licht","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2014.12.006_bb0145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.maturitas.2012.05.007","article-title":"Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations","volume":"72","author":"Lopez-Belmonte","year":"2012","journal-title":"Maturitas"},{"key":"10.1016\/j.pbb.2014.12.006_bb0150","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1590\/0004-2730000003039","article-title":"An overview on the treatment of postmenopausal osteoporosis","volume":"58","author":"Maeda","year":"2014","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1055\/s-0029-1216278","article-title":"Mechanisms of action of estrogen in the brain: insights from human neuroimaging and psychopharmacologic studies","volume":"27","author":"Maki","year":"2009","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.pbb.2014.12.006_bb0160","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1590\/S1519-69842002000400008","article-title":"Determination of the estrous cycle phases of rats: some helpful considerations.","volume":"62","author":"Marcondes","year":"2002","journal-title":"Braz J Biol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0165","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1212\/WNL.48.5_Suppl_7.8S","article-title":"Ovarian steroids and the brain: implications for cognition and aging","volume":"48","author":"McEwen","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2014.12.006_bb0170","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/cne.20128","article-title":"Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses","volume":"473","author":"Merchenthaler","year":"2004","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0175","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1196\/annals.1286.006","article-title":"Estrogen receptor gene expression in relation to neuropsychiatric disorders","volume":"1007","author":"Ostlund","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2014.12.006_bb0180","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.physbeh.2006.02.002","article-title":"Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats","volume":"87","author":"Pandaranandaka","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2014.12.006_bb0185","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.pbb.2014.12.006_bb0190","article-title":"Estrogens, progestins, and risk of breast cancer","volume":"127\u201350","author":"Pike","year":"2007","journal-title":"Ernst Schering Found Symp Proc"},{"key":"10.1016\/j.pbb.2014.12.006_bb0195","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2147\/tcrm.2006.2.3.235","article-title":"Alendronate sodium in the management of osteoporosis","volume":"2","author":"Prinsloo","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.pbb.2014.12.006_bb0200","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbr.2012.05.034","article-title":"Synergistic effect of estradiol and fluoxetine in young adult and middle-aged female rats in two models of experimental depression","volume":"233","author":"Recamier-Carballo","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.pbb.2014.12.006_bb0210","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuropharm.2012.06.039","article-title":"Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity","volume":"64","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.12.006_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuropharm.2012.09.019","article-title":"mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy","volume":"69","author":"Russo","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2014.12.006_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pneurobio.2009.01.009","article-title":"5-HT(1A) receptor function in major depressive disorder","volume":"88","author":"Savitz","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.yfrne.2006.09.004","article-title":"Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS","volume":"27","author":"Scharfman","year":"2006","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neures.2004.02.011","article-title":"Expression of estrogen receptors (alpha, beta) and androgen receptor in serotonin neurons of the rat and mouse dorsal raphe nuclei; sex and species differences","volume":"49","author":"Sheng","year":"2004","journal-title":"Neurosci Res"},{"key":"10.1016\/j.pbb.2014.12.006_bb0235","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jphp.12171","article-title":"Differential impact of the bisphosphonate alendronate on undifferentiated and terminally differentiated human myogenic cells","volume":"66","author":"Shiomi","year":"2014","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0240","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archpsyc.58.6.529","article-title":"Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial","volume":"58","author":"Soares","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2014.12.006_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9220","article-title":"A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis","volume":"9","author":"Stevenson","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.pbb.2014.12.006_bb0250","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0255","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.04.004","article-title":"Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause","volume":"138","author":"Unkila","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.pbb.2014.12.006_bb0260","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pbb.2006.07.003","article-title":"Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats","volume":"86","author":"Walf","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2014.12.006_bb0265","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.psyneuen.2009.01.004","article-title":"Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance","volume":"34","author":"Walf","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pbb.2014.12.006_bb0270","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1073\/pnas.0610282104","article-title":"VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants","volume":"104","author":"Warner-Schmidt","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pbb.2014.12.006_bb0275","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0165-0327(02)00357-9","article-title":"Does estrogen enhance the antidepressant effects of fluoxetine?","volume":"77","author":"Westlund Tam","year":"2003","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pbb.2014.12.006_bb0280","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.gme.0000227861.35226.fa","article-title":"Relative effects of exercise training and alendronate treatment on skeletal muscle function of ovariectomized rats","volume":"14","author":"Widrick","year":"2007","journal-title":"Menopause"},{"key":"10.1016\/j.pbb.2014.12.006_bb0285","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1034\/j.1600-0412.2002.810708.x","article-title":"Patterns of depressed mood across the menopausal transition: approaches to studying patterns in longitudinal data","volume":"81","author":"Woods","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.pbb.2014.12.006_bb0290","doi-asserted-by":"crossref","first-page":"52","DOI":"10.18433\/J3C59H","article-title":"Compositional and material properties of rat bone after bisphosphonate and\/or Strontium ranelate drug treatment","volume":"16","author":"Wu","year":"2013","journal-title":"J Pharm Pharm Sci"},{"key":"10.1016\/j.pbb.2014.12.006_bb0295","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/WNR.0000000000000052","article-title":"Estradiol decreases rat depressive behavior by estrogen receptor beta but not alpha: no correlation with plasma corticosterone","volume":"25","author":"Yang","year":"2014","journal-title":"Neuroreport"},{"key":"10.1016\/j.pbb.2014.12.006_bb0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neubiorev.2012.10.005","article-title":"Neurosteroids, stress and depression: potential therapeutic opportunities","volume":"37","author":"Zorumski","year":"2013","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571400344X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130571400344X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T08:23:27Z","timestamp":1650875007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009130571400344X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":60,"alternative-id":["S009130571400344X"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2014.12.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"type":"print","value":"0091-3057"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2014.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}